Abstract
Background: Plant protease Inhibitors (PIs) play key roles in regulation of many biological activities and being less toxic, more potent and specific in comparision to chemical inhibitors.
Methods: A new proteinaceous trypsin inhibitor was isolated and purified from Macrotyloma uniflorum seeds with a molecular mass of 25 KDa was purified to homogeneity via three sequential purification steps i.e., ammonium sulphate precipitation to CNBr activativated Sepharose 4B coupled trypsin affinity chromatography. Purified protease inhibitor (PI) showed optical specific activities of 665 µmols of tyrosine released/ml/min.
Results: Overall, there was a remarkable increase in the fold of purification. MUTI is stable to denaturation by heat (upto 80°C), pH (4-10).The inhibitory activity increased to two fold in the presence of mercuric chloride and got reduced by half in the presence of ferric chloride. SDS, Dithiothreitol, β-mercaptoethanol, Hydrogen peroxide, Triton X 100 enhanced its inhibitory activity whereas activity was reduced in the presence of DMSO. Chemical modification of the inhibitor by DEPC decreased its activity but the activity was increased considerably when modified with NE and PMSF. Presence of protease inhibitor activity was confirmed by reverse zymography and Dot- blot. Also MUPI has antifungal and antimicrobial properties. MUPI inhibited Phytophthora capsici by 16.6% and Rhizoctonia solani by 27.7%.
Conclusion: Antibacterial activity was shown against Staphylococcus aureus and Pseudomonas aeruginosa. MUPI retained 90% inhibition upon storage at 4°C for over a period of six months. Thus PI can be effectively exploited to increase the shelf life of seafood.
Keywords: Antifungal, Antimicrobial, Protease inhibitor, Macrotyloma uniflorum seeds, Plants, Mechanisms.
Current Topics in Medicinal Chemistry
Title:Antifungal and Antimicrobial Properties of a Purified Protease Inhibitor from Macrotyloma Uniflorum Seeds
Volume: 18 Issue: 29
Author(s): Manju Mohan, Madhu Kumari and Kothanam K. Elyas*
Affiliation:
- Department of Biotechnology, University of Calicut, 673635, Kerala,India
Keywords: Antifungal, Antimicrobial, Protease inhibitor, Macrotyloma uniflorum seeds, Plants, Mechanisms.
Abstract: Background: Plant protease Inhibitors (PIs) play key roles in regulation of many biological activities and being less toxic, more potent and specific in comparision to chemical inhibitors.
Methods: A new proteinaceous trypsin inhibitor was isolated and purified from Macrotyloma uniflorum seeds with a molecular mass of 25 KDa was purified to homogeneity via three sequential purification steps i.e., ammonium sulphate precipitation to CNBr activativated Sepharose 4B coupled trypsin affinity chromatography. Purified protease inhibitor (PI) showed optical specific activities of 665 µmols of tyrosine released/ml/min.
Results: Overall, there was a remarkable increase in the fold of purification. MUTI is stable to denaturation by heat (upto 80°C), pH (4-10).The inhibitory activity increased to two fold in the presence of mercuric chloride and got reduced by half in the presence of ferric chloride. SDS, Dithiothreitol, β-mercaptoethanol, Hydrogen peroxide, Triton X 100 enhanced its inhibitory activity whereas activity was reduced in the presence of DMSO. Chemical modification of the inhibitor by DEPC decreased its activity but the activity was increased considerably when modified with NE and PMSF. Presence of protease inhibitor activity was confirmed by reverse zymography and Dot- blot. Also MUPI has antifungal and antimicrobial properties. MUPI inhibited Phytophthora capsici by 16.6% and Rhizoctonia solani by 27.7%.
Conclusion: Antibacterial activity was shown against Staphylococcus aureus and Pseudomonas aeruginosa. MUPI retained 90% inhibition upon storage at 4°C for over a period of six months. Thus PI can be effectively exploited to increase the shelf life of seafood.
Export Options
About this article
Cite this article as:
Mohan Manju , Kumari Madhu and Elyas K. Kothanam*, Antifungal and Antimicrobial Properties of a Purified Protease Inhibitor from Macrotyloma Uniflorum Seeds, Current Topics in Medicinal Chemistry 2018; 18 (29) . https://dx.doi.org/10.2174/1568026619666181210150923
DOI https://dx.doi.org/10.2174/1568026619666181210150923 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanoemulsions for Improved Efficacy of Phytotherapeutics- A Patent Perspective
Recent Patents on Nanotechnology Emerging Molecular Targets for Treatment of Erectile Dysfunction: Vascular and Regenerative Therapies on the Horizon
Current Drug Targets Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species
Current Neuropharmacology Effects of Micro RNAs and their Targets in Periodontal Diseases
Infectious Disorders - Drug Targets MICA Molecules in Disease and Transplantation, a Double-Edged Sword?
Current Immunology Reviews (Discontinued) Prevention and treatment of atherosclerosis with flaxseed -derived compound secoisolariciresinol diglucoside
Current Pharmaceutical Design Clinical Pharmacokinetics of Ibuprofen Arginine
Current Clinical Pharmacology Molecular, Cellular and Pharmaceutical Aspects of Biomaterials in Dentistry and Oral and Maxillofacial Surgery. An Internationalization of Higher Education and Research Perspective
Current Pharmaceutical Biotechnology Recent Patents Review in Microencapsulation of Pharmaceuticals Using the Emulsion Solvent Removal Methods
Recent Patents on Drug Delivery & Formulation Novel Chromeno[2,3-d]pyrimidines-Design, Synthesis and Antioxidant Activity
Letters in Drug Design & Discovery Molecular Targets in Osteoarthritis: Metalloproteinases and Their Inhibitors
Current Drug Targets Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
Current Pharmaceutical Design <i>Propionibacterium acnes</i> in the Pathogenesis and Immunotherapy of Acne Vulgaris
Current Drug Metabolism Defensin Participation in Innate and Adaptive Immunity
Current Pharmaceutical Design Dental Caries and Vaccination Strategy against the Major Cariogenic Pathogen, Streptococcus mutans
Current Pharmaceutical Biotechnology Inhibition of Matrix Metalloproteinases as a Feasible Therapeutic Target in Rheumatoid Arthritis
Current Rheumatology Reviews Recent Advances in Application of Poly-Epsilon-Caprolactone and its Derivative Copolymers for Controlled Release of Anti-Tumor Drugs
Current Cancer Drug Targets Lactoferrin: A Biologically Active Molecule for Bone Regeneration
Current Medicinal Chemistry Endotoxin, TLR4 Signaling and Vascular Inflammation: Potential Therapeutic Targets in Cardiovascular Disease
Current Pharmaceutical Design Development of Denticap, a Matrix Based Sustained Release Formulation for Treatment of Toothache, Dental Infection and Other Gum Problem
Current Drug Delivery